Archives

Abilify is the Most Commonly Prescribed Antipsychotic Drug Among Newly Diagnosed Bipolar Disorder Patients in the …

BURLINGTON, Mass., Oct. 23, 2014 /PRNewswire/ — Decision Resources Group finds that, through analysis of U.S. Although multiple generic antipsychotics are now available, Abilify's favorably perceived tolerability profile and its regulatory approval for multiple stages of the illness drive its use in bipolar disorder over that of other atypical antipsychotics. Patient share for Lamotrigine in …

Leave a reply